← Back to Analyst Consensus 
NRSN Buy
NeuroSense Therapeutics Ltd.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 3, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| Apr 8, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 25, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 17, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Mar 10, 2026 | Roth Capital | initiate | — → Buy | — | 53% |
| Mar 9, 2026 | D. Boral Capital | maintain | Buy → Buy | — | 34% |
| Dec 22, 2025 | D. Boral Capital | maintain | Buy → Buy | $14 | 34% |
| Nov 24, 2025 | D. Boral Capital | maintain | Buy → Buy | $14 | 34% |
| Aug 15, 2025 | D. Boral Capital | maintain | Buy → Buy | $14 | 34% |
| Jul 10, 2025 | D. Boral Capital | maintain | Buy → Buy | $14 | 34% |
| May 12, 2025 | D. Boral Capital | initiate | — → Buy | $14 | 34% |
| Dec 16, 2024 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
Price Target Trend
Jun 4, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
+1y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days